Gregory Scott Duncan - Jun 21, 2021 Form 4 Insider Report for Virios Therapeutics, Inc. (VIRI)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Greg Duncan
Stock symbol
VIRI
Transactions as of
Jun 21, 2021
Transactions value $
$0
Form type
4
Date filed
6/22/2021, 04:58 PM
Next filing
Dec 22, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIRI Stock Option (right to buy) Award $0 +60K $0.00 60K Jun 21, 2021 Common Stock 60K $6.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests one-third on June 21, 2022 and 1/24th monthly thereafter.